Durvalumab + tremelimumab immune checkpoint inhibition

CP 675206 - CP675206 - CP-675206 - CP-675,206 - CP-675 - P675 cpd - CP 675 - ticilimumab

Head and neck cancer

All type of patients:  3 trials  - Condor - Kestrel - Eagle

durvalumab +/- tremelimumab vs standard treatment

No demonstrated result



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons